Skip to main content
Journal cover image

A STUDY OF TELAPREVIR COMBINED WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN SUBJECTS WITH WELL-DOCUMENTED NON-RESPONSE OR RELAPSE AFTER PREVIOUS PEGINTERFERON-ALFA-2A AND RIBAVIRIN TREATMENT: INTERIM ANALYSIS

Publication ,  Conference
Shiffman, ML; Berg, T; Poordad, FF; Bronowicki, J-P; Muir, AJ; Gordon, SC; George, S; Adda, N; McHutchison, JG
Published in: HEPATOLOGY
October 1, 2008

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2008

Volume

48

Issue

4

Start / End Page

1135A / 1136A

Location

San Francisco, CA

Publisher

JOHN WILEY & SONS INC

Conference Name

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shiffman, M. L., Berg, T., Poordad, F. F., Bronowicki, J.-P., Muir, A. J., Gordon, S. C., … McHutchison, J. G. (2008). A STUDY OF TELAPREVIR COMBINED WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN SUBJECTS WITH WELL-DOCUMENTED NON-RESPONSE OR RELAPSE AFTER PREVIOUS PEGINTERFERON-ALFA-2A AND RIBAVIRIN TREATMENT: INTERIM ANALYSIS. In HEPATOLOGY (Vol. 48, pp. 1135A-1136A). San Francisco, CA: JOHN WILEY & SONS INC.
Shiffman, Mitchell L., Thomas Berg, F Fred Poordad, Jean-Pierre Bronowicki, Andrew J. Muir, Stuart C. Gordon, Shelley George, Nathalie Adda, and John G. McHutchison. “A STUDY OF TELAPREVIR COMBINED WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN SUBJECTS WITH WELL-DOCUMENTED NON-RESPONSE OR RELAPSE AFTER PREVIOUS PEGINTERFERON-ALFA-2A AND RIBAVIRIN TREATMENT: INTERIM ANALYSIS.” In HEPATOLOGY, 48:1135A-1136A. JOHN WILEY & SONS INC, 2008.
Shiffman ML, Berg T, Poordad FF, Bronowicki J-P, Muir AJ, Gordon SC, et al. A STUDY OF TELAPREVIR COMBINED WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN SUBJECTS WITH WELL-DOCUMENTED NON-RESPONSE OR RELAPSE AFTER PREVIOUS PEGINTERFERON-ALFA-2A AND RIBAVIRIN TREATMENT: INTERIM ANALYSIS. In: HEPATOLOGY. JOHN WILEY & SONS INC; 2008. p. 1135A-1136A.
Shiffman ML, Berg T, Poordad FF, Bronowicki J-P, Muir AJ, Gordon SC, George S, Adda N, McHutchison JG. A STUDY OF TELAPREVIR COMBINED WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN SUBJECTS WITH WELL-DOCUMENTED NON-RESPONSE OR RELAPSE AFTER PREVIOUS PEGINTERFERON-ALFA-2A AND RIBAVIRIN TREATMENT: INTERIM ANALYSIS. HEPATOLOGY. JOHN WILEY & SONS INC; 2008. p. 1135A-1136A.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2008

Volume

48

Issue

4

Start / End Page

1135A / 1136A

Location

San Francisco, CA

Publisher

JOHN WILEY & SONS INC

Conference Name

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics